Galantamine plasma concentration and cognitive response in Alzheimer’s disease
Sign Up to like & getrecommendations! Published in 2019 at "PeerJ"
DOI: 10.7717/peerj.6887
Abstract: Background Galantamine has been approved for the treatment of Alzheimer’s disease (AD). However, there are few studies which have reported the association between cognitive responses and galantamine plasma concentration. The aim of this study was… read more here.
Keywords: galantamine; galantamine plasma; plasma concentration; cognitive response ... See more keywords